OMX Nordic 40
|
2 386,18
|
8,47
|
0,36 %
|
Analysen zu OMX Nordic 40-Werten
| 30.01.25 | Nokia Neutral | UBS AG | |
| 30.01.25 | Hennes & Mauritz AB Buy | UBS AG | |
| 30.01.25 | Hennes & Mauritz AB Sell | Goldman Sachs Group Inc. | |
| 30.01.25 | Nokia Sell | Goldman Sachs Group Inc. | |
| 30.01.25 | Hennes & Mauritz AB Sector Perform | RBC Capital Markets | |
| 30.01.25 | ABB Neutral | Goldman Sachs Group Inc. | |
| 30.01.25 | ABB Sector Perform | RBC Capital Markets | |
| 29.01.25 | Novo Nordisk Buy | UBS AG | |
| 29.01.25 | Volvo AB Sector Perform | RBC Capital Markets | |
| 29.01.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 29.01.25 | Volvo AB Neutral | UBS AG | |
| 29.01.25 | Ericsson Hold | Deutsche Bank AG | |
| 29.01.25 | Volvo AB Buy | Goldman Sachs Group Inc. | |
| 29.01.25 | Volvo AB Overweight | JP Morgan Chase & Co. | |
| 28.01.25 | Nokia Overweight | JP Morgan Chase & Co. | |
| 28.01.25 | ABB Underperform | Bernstein Research | |
| 28.01.25 | Novo Nordisk Buy | UBS AG | |
| 27.01.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 27.01.25 | Hennes & Mauritz AB Underweight | JP Morgan Chase & Co. | |
| 27.01.25 | Hennes & Mauritz AB Hold | Jefferies & Company Inc. | |
| 24.01.25 | Novo Nordisk Buy | UBS AG | |
| 24.01.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 24.01.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 24.01.25 | Ericsson Underweight | Barclays Capital | |
| 24.01.25 | Ericsson Neutral | JP Morgan Chase & Co. | |
| 24.01.25 | Ericsson Sell | Goldman Sachs Group Inc. | |
| 24.01.25 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 24.01.25 | Ericsson Sell | UBS AG | |
| 23.01.25 | ABB Neutral | JP Morgan Chase & Co. | |
| 23.01.25 | Volvo AB Neutral | UBS AG | |
| 22.01.25 | Ericsson Neutral | JP Morgan Chase & Co. | |
| 21.01.25 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 21.01.25 | Novo Nordisk Buy | UBS AG | |
| 20.01.25 | ABB Underperform | Bernstein Research | |
| 20.01.25 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 17.01.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 17.01.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 17.01.25 | Novo Nordisk Buy | UBS AG | |
| 17.01.25 | Volvo AB Buy | Jefferies & Company Inc. | |
| 16.01.25 | Volvo AB Neutral | UBS AG |
HOT STOCKS DER LETZTEN 3 TAGE
Analysen zu Aktien folgender Indizes
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.